Literature DB >> 26930525

An open-label, pilot trial of adjunctive tocilizumab in schizophrenia.

Brian J Miller1, James K Dias, Henrique P Lemos, Peter F Buckley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26930525     DOI： 10.4088/JCP.15l09920

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  26 in total

1.  Inflammation in individuals with schizophrenia - Implications for neurocognition and daily function.

Authors:  Sophia Kogan; Luz H Ospina; David Kimhy
Journal:  Brain Behav Immun       Date:  2018-09-12       Impact factor: 7.217

2.  Psychosis as an adverse effect of monoclonal antibody immunotherapy.

Authors:  Norah Essali; David R Goldsmith; Laura Carbone; Brian J Miller
Journal:  Brain Behav Immun       Date:  2019-06-03       Impact factor: 7.217

3.  Progress in Schizophrenia Research and Treatment.

Authors: 
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

4.  Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

5.  A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, An Interleukin-6 Receptor Antibody, For Residual Symptoms in Schizophrenia.

Authors:  Ragy R Girgis; Adam Ciarleglio; Tse Choo; Gregory Haynes; Joan M Bathon; Serge Cremers; Joshua T Kantrowitz; Jeffrey A Lieberman; Alan S Brown
Journal:  Neuropsychopharmacology       Date:  2017-11-01       Impact factor: 7.853

Review 6.  Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Neuropsychopharmacology       Date:  2016-09-22       Impact factor: 7.853

Review 7.  Effects of Antipsychotic Drugs: Cross Talk Between the Nervous and Innate Immune System.

Authors:  Ayushi Anna Dinesh; Juned Islam; Javad Khan; Federico Turkheimer; Anthony C Vernon
Journal:  CNS Drugs       Date:  2020-09-25       Impact factor: 5.749

8.  Targeting the Immune System with Pharmacotherapy in Schizophrenia.

Authors:  Jennifer K Melbourne; Benjamin Feiner; Cherise Rosen; Rajiv P Sharma
Journal:  Curr Treat Options Psychiatry       Date:  2017-04-18

Review 9.  The impact of inflammation on neurocognition and risk for psychosis: a critical review.

Authors:  Sophia Kogan; Luz H Ospina; Vijay A Mittal; David Kimhy
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-10-16       Impact factor: 5.270

10.  The Role of Cytokines in Predicting the Efficacy of Acute Stage Treatment in Patients with Schizophrenia.

Authors:  Xiaoyan He; Qingyan Ma; Yajuan Fan; Binbin Zhao; Wei Wang; Feng Zhu; Xiancang Ma; Lina Zhou
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-21       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.